Source: Annual Congress 2011 - Novel mechanisms in lung injury
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
H. Sugiura, A. Koarai, T. Ichikawa, M. Ichinose (Wakayama, Japan). Possible role of 25-hydroxycholesterol on the pahogenesis of chronic obstructive pulmonary. Eur Respir J 2011; 38: Suppl. 55, 3903

Member's Comments

No comment yet.

Related content which might interest you: Role of inhaled antioxidants in chronic obstructive pulmonary disease Source: Eur Respir J 2005; 26: Suppl. 49, 717s Year: 2005 Regulation disorders of pulmonary lipid metabolism in chronic obstructive pulmonary disease Source: International Congress 2019 – Research and innovation in airway diseases Year: 2019 The role of inflamatory markers in obstructive pulmonary disease Source: Annual Congress 2012 - Distinguishing phenotypes and dealing with comorbidities in primary care Year: 2012 Rhinovirus-infection in chronic obstructive pulmonary disease Source: Eur Respir J 2002; 20: Suppl. 38, 591s Year: 2002 Can ADMA play a role in determining pulmonary hypertension related to chronic obstructive lung disease? Source: International Congress 2016 – Pulmonary hypertension in lung disease Year: 2016 Effects of severity of chronic obstructive pulmonary disease on thyroid function Source: Eur Respir J 2005; 26: Suppl. 49, 509s Year: 2005 Mechanisms in chronic obstructive pulmonary disease: comparisons with asthma Source: Annual Congress 2008 - PG17 - An expert view of the differences between asthma and COPD Year: 2008 Antioxidant properties of N-acetylcysteine: their relevance in relation to chronic obstructive pulmonary disease Source: Eur Respir J 2004; 23: 629-636 Year: 2004 Systemic effects of chronic obstructive pulmonary disease Source: Eur Respir J 2003; 21: 347-360 Year: 2003 The effect of nutrition on the pulmonary functions in chronic obstructive pulmonary disease Source: Eur Respir J 2003; 22: Suppl. 45, 538s Year: 2003 Novel compounds for WNT/ß-catenin induced lung repair in chronic obstructive pulmonary disease Source: International Congress 2018 – Regenerative and anti-fibrotic approaches Year: 2018 Oxidant metabolism in chronic obstructive pulmonary disease Source: Eur Respir J 2003; 22: 14S-27S Year: 2003 Role of oxidative-antioxidative imbalance and thyroid hormones in stable chronic obstructive pulmonary disease Source: Annual Congress 2009 - COPD: exacerbation and clinical problems Year: 2009 Systemic inflammation in chronic obstructive pulmonary disease Source: Eur Respir J 2003; 22: 5S-13S Year: 2003 Chronic obstructive pulmonary disease Source: Eur Respir Monogr 2014; 65: 1-17 Year: 2014 Chronic obstructive pulmonary disease Source: Eur Respir Monogr 2015; 70: 80-98 Year: 2015 Chronic obstructive pulmonary disease Source: Eur Respir Mon; 2009: 45: 25–31 Year: 2009 Chronic obstructive pulmonary disease Source: Eur Respir Monogr 2013; 62: 1-18 Year: 2013 Epigenetic-like regulation of signalling proteins in chronic obstructive pulmonary disease Source: International Congress 2019 – Effects of environmental exposures in lung pathology and the underlying mechanisms Year: 2019 Erythropoietin dysregulation in chronic obstructive pulmonary disease Source: Annual Congress 2008 - COPD Year: 2008